They observed a significant delay in tumor growth in mice that received the treatment combination in comparison to those received either treatment alone, and this inhibition was associated with an increase in tumor infiltration of CD4+ and CD8+ T cells [137]. This evidence concerns the gene CD8A and neoplasm.